Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
30 years on and still more to do to educate gay men about HIV prevention

Thirty years after the discovery of virus, new research from NAT (National AIDS Trust) reveals that gay men are in the dark about new HIV prevention tools, with knowledge among 16-24 year olds particularly low.

Published
23 April 2014
From
NAT press release
Gilead Sciences’ New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDA

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s refiling of two New Drug Applications (NDA) for cobicistat, a pharmacoenhancing or “boosting” agent that increases blood levels of the protease inhibitors atazanavir and darunavir to enable once-daily dosing of these medicines in HIV therapy, and elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced adults.

Published
22 April 2014
From
Gilead press release
People living with HIV in the UK still have impaired health-related quality of life

People living with HIV in the UK have poorer health-related quality of life (HRQoL) compared to individuals in the general population, according to research presented at the

Published
22 April 2014
By
Michael Carter
As a doctor, I’d rather have HIV than diabetes

One of the most feared diseases in the world is now, for British doctors, a manageable chronic condition. It’s a triumph we’re oddly scared to talk about

Published
17 April 2014
From
The Spectator
Px Wire: Long-Acting Injectables

In this issue, we review the research on long-acting injectable antiretrovirals for treatment in HIV-positive people and PrEP in HIV-negative people. The pathways for developing these products have key similarities as well as differences—and as the same drugs advance for treatment and PrEP, it will be key to communicate these.

Published
17 April 2014
From
AVAC
Abolishing HIV in Rwanda

The achievement of universal HIV coverage in one African country, Rwanda, has resulted in HIV diagnoses more than halving and annual incidence falling by 90%, the 2014 Treatment

Published
16 April 2014
By
Gus Cairns
Bristol-Myers Squibb Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of Atazanavir Sulfate with Cobicistat for People Living with HIV-1

If approved, atazanavir sulfate and cobicistat could offer patients living with HIV-1 a single tablet that eliminates the need to take a boosting agent in a separate tablet. Cobicistat is developed by Gilead Sciences, Inc.

Published
15 April 2014
From
Bristol-Myers Squibb press release
Get More from Your Medical Care: Seven Resources Show You How

How can you fit medical regular appointments into your life—and get more out of them? The seven resources below can help you understand how doctors think, boost communication with your medical provider (or find a new one), and keep up with regular appointments.

Published
14 April 2014
From
BETA blog
South Africa: ARV Programme Saves 780 000 Lives

South Africa's HIV antiretroviral treatment programme saved 780 000 lives between 2003 and 2012, according to a recently released independent review. But the tuberculosis programme is failing to meet targets.

Published
14 April 2014
From
Health-e
Transplant Drugs May Fight HIV Reservoir

Immunosuppressant drugs used to prevent rejction of transplanted organs may combat the HIV reservoir.

Published
14 April 2014
From
AIDSMeds
← First12345...351Next →

Filter by country